Internal Medicine, Infectious Disease · Mattoon, IL
NPI
1407812746
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 Health Center Dr Ste 302
Mattoon, IL, 61938
Phone (217) 238-4770
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,037 services
Medicare patients, 2024
222
Average age 73
Drug cost, 2024
$94K
452 prescriptions
Company payments, 2024
$18.62
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Venkat R Minnaganti was code 99232 (hospital e&m - subsequent), 479 times for 179 patients. In total Venkat R Minnaganti billed 1,037 services in 6 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 479 | 179 | $59.56 | $29K |
| 99233 Hospital E&M - Subsequent | Facility | 282 | 97 | $89.49 | $25K |
| 99223 Hospital E&M - Initial | Facility | 147 | 123 | $132.29 | $19K |
| 99222 Hospital E&M - Initial | Facility | 104 | 92 | $97.66 | $10K |
| 99291 Critical Care E&M | Facility | 23 | 21 | $164.48 | $3,783 |
By year: 2022 $105K for 1,186 services; 2023 $69K for 810 services; 2024 $87K for 1,037 services.
Medicare prescription drug claims, 2024
In 2024, the drug Venkat R Minnaganti prescribed most often to Medicare patients was Levofloxacin, with 59 prescriptions and refills. In total Venkat R Minnaganti wrote 452 Medicare prescriptions that cost $94K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levofloxacin Generic | 59 | 59 | 55 | $265 |
| Daptomycin Generic | 53 | 53 | Under 11 | $29K |
| Ceftriaxone Ceftriaxone Sodium | 47 | 47 | 17 | $1,626 |
| Vancomycin Hcl Generic | 42 | 42 | 14 | $11K |
| Nafcillin Sodium Generic | 33 | 33 | Under 11 | $20K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 32 | 32 | 30 | $225 |
| Ertapenem Ertapenem Sodium | 30 | 30 | 11 | $18K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 19 | 16 | $39.24 |
| Metronidazole Generic | 19 | 19 | 19 | $189 |
| Cefazolin Sodium Generic | 19 | 19 | Under 11 | $880 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 16 | 16 | Under 11 | $4,233 |
| Ceftriaxone Ceftriaxone In Is-Osm Dextrose | 13 | 13 | Under 11 | $1,350 |
| Meropenem Generic | 12 | 12 | Under 11 | $3,801 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $345 |
| Vancomycin Hcl Vancomycin/Water For Inj (Peg) | 11 | 11 | Under 11 | $353 |
Brand drugs: 29 claims; generic drugs: 423 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Venkat R Minnaganti $18.62 ($18.62 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $18.62.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $18.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.